Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2022-23 | Page 129

### Consolidated Statement of Cash Flows

| Particulars | Notes | July 2022-June 2023 | July 2021-June 2022 |
| --- | --- | --- | --- |
| Cash Flows from Operating Activities : |  |  |  |
| Receipts from Customers and Others |  | 39,440,236,428 | 36,145,521,249 |
| Payments to Suppliers and Employees |  | (30,943,666,211) | (28,584,815,294) |
| Cash Generated from Operations |  | 8,496,570,217 | 7,560,705,955 |
| Interest Paid |  | (1,272,368,534) | (1,002,350,838) |
| Interest Received |  | 5,529,516 | 3,055,358 |
| Income Tax Paid |  | (1,144,944,341) | (1,347,234,025) |
| Net Cash Generated from Operating Activities | 35 | 6,084,786,858 | 5,214,176,450 |
| Cash Flows from Investing Activities : |  |  |  |
| Acquisition of Property, Plant and Equipment |  | (2,410,765,411) | (2,815,211,828) |
| Intangible Assets |  | (299,262,244) | (124,286,166) |
| Investment in Subsidiary |  | - | (4,766,635,704) |
| Disposal of Property, Plant and Equipment |  | 23,353,504 | 24,063,832 |
| Disposal of Intangible Assets |  | 67,725,000 | - |
| Dividend Received |  | 1,931,517 | 2,015,444 |
| Net Cash Used in Investing Activities |  | (2,617,017,634) | (7,680,054,422) |
| Cash Flows from Financing Activities : |  |  |  |
| Net Increase /(Decrease) in Long Term Borrowings |  | (1,763,267,386) | 2,730,647,211 |
| Net Increase/(Decrease) in Short Term Borrowings |  | (229,380,048) | 1,507,676,748 |
| Dividend Paid |  | (1,567,923,375) | (1,623,098,759) |
| Net Cash (Used in) / from Financing Activities |  | (3,560,570,809) | 2,615,225,200 |
| Increase/(Decrease) in Cash and Cash Equivalents |  | (92,801,585) | 149,347,228 |
| Cash and Cash Equivalents at Beginning of Year |  | 1,168,673,821 | 973,963,625 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 35 | 59,813,942 | 45,362,968 |
| Cash and Cash Equivalents at End of Year | 12 | 1,135,686,178 | 1,168,673,821 |
| Net Operating Cash Flows Per Share | 34 | 13.64 | 11.69 |